IMPACT OF ALPHA-ADRENERGIC CORONARY VASOCONSTRICTION ON THE TRANSMURAL MYOCARDIAL BLOOD-FLOW DISTRIBUTION DURING HUMORAL AND NEURONAL ADRENERGIC ACTIVATION

Citation
D. Baumgart et al., IMPACT OF ALPHA-ADRENERGIC CORONARY VASOCONSTRICTION ON THE TRANSMURAL MYOCARDIAL BLOOD-FLOW DISTRIBUTION DURING HUMORAL AND NEURONAL ADRENERGIC ACTIVATION, Circulation research, 73(5), 1993, pp. 869-886
Citations number
46
Categorie Soggetti
Hematology,"Cardiac & Cardiovascular System
Journal title
ISSN journal
00097330
Volume
73
Issue
5
Year of publication
1993
Pages
869 - 886
Database
ISI
SICI code
0009-7330(1993)73:5<869:IOACVO>2.0.ZU;2-Q
Abstract
Increased heart rate and left ventricular pressure during humoral and neuronal adrenergic activation act to restrict blood flow preferential ly in the subendocardium. The hypothesis was advanced that alpha-adren ergic coronary vasoconstriction preferentially in the subepicardium ma y counterbalance the enhanced extravascular compression in the subendo cardium and serve to maintain blood flow transmurally uniform. In 40 a nesthetized dogs, regional myocardial blood flow was determined with c olored microspheres; wall function, with sonomicrometry. Humoral adren ergic activation (HAA) was induced by a combination of intravenous atr opine, intravenous norepinephrine, and atrial pacing during baseline c oronary vasomotor tone (group 1, n = 6) and in the presence of maximal coronary vasodilation with intravenous dipyridamole (group 2, n = 6). In an additional group, HAA was induced by intravenous norepinephrine in the presence of dipyridamole but without atropine and atrial pacin g in order to increase end-diastolic left ventricular pressure (group 3, n = 6). Measurements were performed at rest, during HAA, and during ongoing HAA with the intracoronary infusion of the alpha-antagonist p hentolamine (Phen). At unchanged mean aortic pressure, Phen improved b lood flow particularly to the inner layers as follows: from 1.42 +/- 0 .40 (mean +/- SD) to 1.90 +/- 0.40 mL/(min.g) (group 1, P < .05), from 4.99 +/- 2.31 to 5.53 +/- 2.56 mL/(min.g) (group 2, P < .05), and fro m 6.01 +/- 1.41 to 6.29 +/- 1.27 mL/(min.g) (group 3, P < .05), associ ated with a decrease in outer layer blood flow in groups 2 and 3. In 1 6 additional dogs, beta-adrenoceptors were blocked by propranolol and muscarinic receptors by atropine. Neuronal adrenergic activation (NAA) was induced by cardiac sympathetic nerve stimulation (CSNS) during ba seline coronary vasomotor tone (group 4, n = 8) and in the presence of maximal vasodilation (group 5, n = 8). Measurements were performed at rest, during a first CSNS, and 20 minutes later during a second CSNS + Phen. The reproducibility of two consecutive episodes of CSNS 20 min utes apart was demonstrated in a separate set of experiments (n = 6). At matched mean aortic pressures, Phen improved blood flow to all myoc ardial layers in group 4, whereas in group 5, Phen induced a redistrib ution of myocardial blood flow toward subepicardial layers [from 4.44 +/- 0.96 to 4.81 +/- 0.83 mL/(min.g), P < .05] at the expense of inner layers. With the addition of Phen, there was no change in regional wa ll function in any group of dogs studied. Thus, during HAA, alpha-adre nergic coronary vasoconstriction does not exert a beneficial effect on transmural blood flow distribution. During NAA, a beneficial effect o f a-adrenergic coronary vasoconstriction becomes apparent only under c onditions of maximal coronary vasodilation.